hta_admin | Health Technology Assessment Division

[Department Memorandum No. 2022- 0379] Updated Checklist of Requirements for the Health Technology Assessment of COVID-19 Health Technologies to be referred by the Disease Prevention and Control Bureau (DPCB) and National Vaccine Operations Center (NVOC)

Posted on September 2, 2022

HTAC Guidance: Self-Administered Antigen Test Kits (SAAgT)

Posted on August 25, 2022

The HTAC and its review of health technologies To ensure equitable access to quality and affordable health care to Filipinos, the Health Technology Assessment Council (HTAC) was created under the Universal Healthcare Act of 2019 (Republic Act No. 11223). The HTAC provides technical guidance on the optimal use of health technologies including clinical equipment and devices (i.e., medical continue reading : HTAC Guidance: Self-Administered Antigen Test Kits (SAAgT)

Revised HTAC Preliminary Recommendation on the Inclusion of Insulin Glargine and the Non-Inclusion of Insulin Detemir in the PNF

Posted on August 23, 2022

Link to appeals form here: Topic Nomination (stakeholders may submit appeals to hta@doh.gov.ph until 07 September 2022.) Document Preview:

[Department Circular No. 2022- 0400] Change in the Generic Name of “Nicotine Polacrilex Medicated Chewing Gum” in the Philippine National Formulary (PNF) to “Nicotine”

Posted on August 4, 2022

Preliminary Recommendation for the Inclusion of Insulin Glargine and Insulin Detemir for Type 1 and Type 2 Diabetes Mellitus in the PNF

Posted on July 26, 2022